go back

New Mexico rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $870,964 · 10th–90th $562,341–$1,949,8450%20%10th90th$870,964Professionalmedian $562,341 · 10th–90th $562,341–$870,9640%50%90th$562,341$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$602,559.59 / $870,963.59 / $1,949,844.60
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $870,963.59
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$524,807.46 / $562,341.33 / $870,963.59
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $524,807.46 / $524,807.46